Science 37 Number Of Shares Shorted vs. Revenue
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
For Science 37 profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Science 37 to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Science 37 Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Science 37's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Science 37 Holdings over time as well as its relative position and ranking within its peers.
Science |
Science 37 Holdings Revenue vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Science 37's current stock value. Our valuation model uses many indicators to compare Science 37 value to that of its competitors to determine the firm's financial worth. Science 37 Holdings is rated below average in number of shares shorted category among its peers. It is rated fourth in revenue category among its peers totaling about 4,356 of Revenue per Number Of Shares Shorted. Comparative valuation analysis is a catch-all technique that is used if you cannot value Science 37 by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Science Revenue vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Science 37 |
| = | 13.83 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Science 37 |
| = | 60.26 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Science Revenue vs Competition
Science 37 Holdings is rated fourth in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 948.78 Million. Science 37 holds roughly 60.26 Million in revenue claiming about 6% of equities under Health Care industry.
Science 37 Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Science 37, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Science 37 will eventually generate negative long term returns. The profitability progress is the general direction of Science 37's change in net profit over the period of time. It can combine multiple indicators of Science 37, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people.
Science Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Science 37. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Science 37 position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Science 37's important profitability drivers and their relationship over time.
Use Science 37 in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Science 37 position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science 37 will appreciate offsetting losses from the drop in the long position's value.Science 37 Pair Trading
Science 37 Holdings Pair Trading Analysis
The ability to find closely correlated positions to Science 37 could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Science 37 when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Science 37 - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Science 37 Holdings to buy it.
The correlation of Science 37 is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Science 37 moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Science 37 Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Science 37 can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Science 37 position
In addition to having Science 37 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Petroleum and Natural Gas Thematic Idea Now
Petroleum and Natural Gas
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |